Skip to main content
. 2008 Nov;10(6):502–512. doi: 10.2353/jmoldx.2008.080054

Table 2.

Immunophenotypic Findings of ALCL Cases

Positive cases/cases studied [n/n(%)]
Diagnosis Cases (n) CD2 CD3 CD15 CD43 CD30 ALK EMA
ALK+ ALCL 28 8/18 (44) 4/25 (16) 0/7 (0) 11/17 (65) 28/28 (100) 28/28 (100) 8/11 (73)
ALK ALCL 35 9/14 (64) 16/32 (50) 1/12 (8) 16/23 (70) 35/35 (100) 0/35 (0) 4/13 (31)
Total 63 17/32 (53) 20/57 (35) 1/19 (5) 27/40 (68) 63/63 (100) 28/63 (44) 12/24 (50)